Citation 13603
LO,WL: WU,CC: CHANG,FR: WANG,WY: KHALIL,AT: LEE,KH: WU,YC:. (2003). ANTIPLATELET AND ANTI-HIV CONSTITUTENTS FROM EUCHRESTA FORMOSANA.. 17(2)
Citation Details
| Title | ANTIPLATELET AND ANTI-HIV CONSTITUTENTS FROM EUCHRESTA FORMOSANA. |
|---|---|
| Authors | LO,WL: WU,CC: CHANG,FR: WANG,WY: KHALIL,AT: LEE,KH: WU,YC: |
| Year | 2003 |
| Volume | 17 |
| Issue | 2 |
Summary
Year: 2003
Journal: Unknown
Organisms and Their Experiments (1)
Euchresta formosana (FABACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | ||
| 2 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 3 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 4 |
PLATELET AGGREGATION INHIBITION
|
INACTIVE
|
||
| 5 |
PLATELET AGGREGATION INHIBITION
|
INACTIVE
|
||
| 6 | Not specified |
EUCHRETIN JEUCHRETIN MEUCHRETIN NFORMOSANATIN AFORMOSANATIN CVANILLINEUCHRENONE A-2EUCHRENONE B-1VOMIFOLIOLFLAVONE,ISO: 4'-6-7-TRIHYDROXY:FLAVONE,ISO: 3'-4'-5-TRIHYDROXY:CHROMEN-4-ONE,5-7-DIHYDROXY-3-(2-HYDROXY-4-METHOXY-PHENYL):FLEMIPHYLLINCHROMEN-4-ONE,7-HYDROXY-3-(2-HYDROXY-4-METHOXY-PHENYL):PTEROCARPINBIOCHANIN AQUERCETINGENISTEINPHEOPHYTIN AEUCHRETIN AFORMONONETINEUCHRETIN CEUCHRESTAFLAVANONE AEUCHRETIN DEUCHRETIN FEUCHRETIN HEUCHRENONE B-16EUCHRETIN IEUCHRENONE B-2MAACKIAINTRIFOLIRHIZINMATRINECYTISINE
| None | |
| 7 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 8 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 9 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 10 |
PLATELET AGGREGATION INHIBITION
|
INACTIVE
|
||
| 11 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 12 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 13 |
PLATELET AGGREGATION INHIBITION
|
INACTIVE
|
||
| 14 |
PLATELET AGGREGATION INHIBITION
|
INACTIVE
|
||
| 15 |
ANTIVIRAL ACTIVITY
|
INACTIVE
|
||
| 16 |
ANTIVIRAL ACTIVITY
|
INACTIVE
|
||
| 17 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 18 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 19 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 20 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 21 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 22 |
ANTIMUTAGENIC ACTIVITY
|
INACTIVE
|
||
| 23 |
ANTIVIRAL ACTIVITY
|
ACTIVE
|
||
| 24 |
ANTISICKLING ACTIVITY
|
ACTIVE
|
||
| 25 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 26 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 27 |
ANTIVIRAL ACTIVITY
|
INACTIVE
|
||
| 28 |
PLATELET AGGREGATION INHIBITION
|
INACTIVE
|
||
| 29 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 30 |
PLATELET AGGREGATION INHIBITION
|
INACTIVE
|
||
| 31 |
PLATELET AGGREGATION INHIBITION
|
INACTIVE
|
||
| 32 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 33 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 34 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 35 |
PLATELET AGGREGATION INHIBITION
|
INACTIVE
|
||
| 36 |
ANTIVIRAL ACTIVITY
|
ACTIVE
|
||
| 37 |
ANTIVIRAL ACTIVITY
|
INACTIVE
|
||
| 38 |
ANTIVIRAL ACTIVITY
|
INACTIVE
|
||
| 39 |
ANTIVIRAL ACTIVITY
|
INACTIVE
|
||
| 40 |
ANTIVIRAL ACTIVITY
|
INACTIVE
|
||
| 41 |
ANTIVIRAL ACTIVITY
|
INACTIVE
|
||
| 42 |
ANTIVIRAL ACTIVITY
|
INACTIVE
|
||
| 43 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 44 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 45 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 46 |
PLATELET AGGREGATION INHIBITION
|
INACTIVE
|
||
| 47 |
ANTIVIRAL ACTIVITY
|
INACTIVE
|
||
| 48 |
ANTIVIRAL ACTIVITY
|
INACTIVE
|
||
| 49 |
ANTIVIRAL ACTIVITY
|
INACTIVE
|
||
| 50 |
ANTIVIRAL ACTIVITY
|
ACTIVE
|
||
| 51 |
ANTIVIRAL ACTIVITY
|
INACTIVE
|
||
| 52 |
ANTIVIRAL ACTIVITY
|
INACTIVE
|
||
| 53 |
ANTIVIRAL ACTIVITY
|
ACTIVE
|
||
| 54 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 55 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 56 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 57 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 58 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 59 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 60 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|
||
| 61 |
PLATELET AGGREGATION INHIBITION
|
ACTIVE
|